Search Results - "Pinheiro, Amelia Alvez"
-
1
Clinical and demographic aspects of secondary progressive multiple sclerosis in Argentina
Published in Medicina (2020)“…The objective of the study was to describe the clinical and demographic aspects of patients with secondary progressive multiple sclerosis (SPMS) included in…”
Get more information
Journal Article -
2
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
Published in Clinical neuropharmacology (01-07-2024)“…The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis in Argentina…”
Get full text
Journal Article -
3
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
Published in Clinical neuropharmacology (01-07-2024)“…The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis in Argentina…”
Get full text
Journal Article -
4
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
Published in Neurological sciences (01-02-2024)“…We aimed to evaluate the incidence of SARS-CoV-2 breakthrough infection of SARS-CoV-2 vaccines in people with MS (PwMS) on high-efficacy disease-modifying…”
Get full text
Journal Article -
5
Consensus recommendations on the management of multiple sclerosis patients in Argentina
Published in Journal of the neurological sciences (15-02-2020)“…During the last 20 years, multiple sclerosis (MS) disease has seen major changes with new diagnostic criteria, a better identification of disease phenotypes,…”
Get full text
Journal Article -
6
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)
Published in Neurological sciences (01-06-2020)“…The objective of this study was to describe and compare the baseline epidemiological data of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder…”
Get full text
Journal Article -
7
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients
Published in Journal of the neurological sciences (15-02-2018)“…One of the biggest challenges in multiple sclerosis (MS) is the definition of treatment response/failure in order to optimize treatment decisions in affected…”
Get full text
Journal Article -
8
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions
Published in Multiple sclerosis and related disorders (01-07-2019)“…•No ongoing nationwide registry exists in Latin America.•We describe the methodology behind RelevarEM, the first nationwide MS registry in Argentina and…”
Get full text
Journal Article -
9
Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM
Published in Journal of clinical neuroscience (01-07-2021)“…•We describe and compare baseline characteristics in AMS and non-AMS in Argentina.•2158 patients with MS were included: 74 AMS and 2084 non-AMS.•The prevalence…”
Get full text
Journal Article -
10
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)
Published in Multiple sclerosis and related disorders (01-04-2021)“…•RelevarEM is the first nationwide MS and NMOSD registry in Argentina•Patients with phenotype of suspected NMOSD were evaluated•165 patients (79 AQP4-ab…”
Get full text
Journal Article -
11